Literature DB >> 19758208

The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies.

Yoav Arnson1, Howard Amital, Serena Guiducci, Marco Matucci-Cerinic, Gabriele Valentini, Ori Barzilai, Ram Maya, Yehuda Shoenfeld.   

Abstract

Infections are believed to often play a role in the immunopathogenesis of autoimmune disorders; such is the case in systemic sclerosis (SSc). In order to evaluate the potential role infections may have on the pathogenesis of SSc, we assessed serological reactivity against various infectious agents in patients with SSc and compared them with healthy controls. Serological samples obtained from 80 patients with SSc were compared with 296 compatible healthy controls. Both groups were of European origin. All samples were tested for the presence of antibodies directed against hepatitis B virus, hepatitis C virus, toxoplasmosis, rubella, CMV, EBV, and Treponema pallidum. We applied Bio-Rad commercial and experimental kits to assess most antigens and ELISA assays to complete the panel. Patients with SSc had elevated IgM and IgG against Toxoplasma gondii and against CMV. Higher titers were also detected against the hepatitis B virus core protein (recombinant HBc antigen) using MONOLISA anti-HBc Plus commercial kit (Bio-Rad). A significantly higher rate of IgM antibodies against the capsid antigen of the EBV was detected in SSc patients compared with healthy controls, as well. These data demonstrate that antibodies against CMV, HBV, and toxoplasmosis were detected more often in patients with SSc. This association implies that infectious agents may have a role in disease pathogenesis and expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758208     DOI: 10.1111/j.1749-6632.2009.04808.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

1.  Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.

Authors:  Yinon Shapira; Bat-Sheva Poratkatz; Boris Gilburd; Ori Barzilai; Maya Ram; Miri Blank; Staffan Lindeberg; Johan Frostegård; Juan-Manuel Anaya; Nicola Bizzaro; Luis J Jara; Jan Damoiseaux; Yehuda Shoenfeld; Nancy Agmon Levin
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 2.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

3.  Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.

Authors:  Emmanouela Marou; Christos Liaskos; Theodora Simopoulou; Georgios Efthymiou; Efthymios Dardiotis; Christina Katsiari; Thomas Scheper; Wolfgang Meyer; Georgios Hadjigeorgiou; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2017-01-26       Impact factor: 2.980

4.  Chronic hepatitis C viral infection among SLE patients: the significance of coexistence.

Authors:  Naim Mahroum; Ashraf Hejly; Shmuel Tiosano; Omer Gendelman; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

5.  Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension.

Authors:  Stefania Lenna; Alessandra G Farina; Viktor Martyanov; Romy B Christmann; Tammara A Wood; Harrison W Farber; Raffaella Scorza; Michael L Whitfield; Robert Lafyatis; Maria Trojanowska
Journal:  Arthritis Rheum       Date:  2013-05

Review 6.  Fresh Insights into Disease Etiology and the Role of Microbial Pathogens.

Authors:  Antonella Farina; G Alessandra Farina
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

7.  Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis.

Authors:  Irene Soffritti; Maria D'Accolti; Gloria Ravegnini; Maria-Cristina Arcangeletti; Clara Maccari; Flora De Conto; Adriana Calderaro; Elisabetta Caselli
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

8.  Diffuse Systemic Sclerosis in a Patient with Primary Biliary Cirrhosis and Autoimmune Hepatitis Overlap Syndrome: A Case Report.

Authors:  Hye Sung Han; Ga Ram Ahn; Hyung Joon Kim; Kui Young Park; Kapsok Li; Seong Jun Seo
Journal:  Ann Dermatol       Date:  2019-12-27       Impact factor: 1.444

9.  Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma.

Authors:  Antonella Farina; Mara Cirone; Michael York; Stefania Lenna; Cristina Padilla; Sarah Mclaughlin; Alberto Faggioni; Robert Lafyatis; Maria Trojanowska; Giuseppina A Farina
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

10.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.